Combination therapies with CK2 modulators

Details for Australian Patent Application No. 2010274165 (hide)

Owner Cylene Pharmaceuticals, Inc.

Inventors Drygin, Denis; Anderes, Kenna; Ho, Caroline B.; Bliesath, Joshua R.; Proffitt, Christopher B.; O'Brien, Sean; Rice, William G.

Agent Baldwins

Pub. Number AU-A-2010274165

PCT Pub. Number WO2011/011199

Priority 12/684,053 07.01.10 US; 61/262,079 17.11.09 US; 61/228,121 23.07.09 US

Filing date 7 July 2010

Wipo publication date 27 January 2011

International Classifications

A61K 31/4745 (2006.01)

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

15 March 2012 PCT application entered the National Phase

  PCT publication WO2011/011199 Priority application(s): WO2011/011199

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010274166-Pre-sulfiding and pre-conditioning of residuum hydroconversion catalysts for ebullated-bed hydroconversion processes

2010274152-Methods for synthesizing polytrimethylene ether glycol and copolymers thereof